Golidocitinib favorable for relapsed/refractory T-cell lymphoma. Nierengarten MB. Cancer 2024;130:1191-1192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Golidocitinib favorable for relapsed/refractory T-cell lymphoma. Cancer 2024;130:1191-1192.
PMID: 38498282